Tetratherix Ltd Market Cap ($199.36 Million)
Market Cap & Net Worth: Tetratherix Ltd (TTX)
Tetratherix Ltd market cap. Tetratherix Ltd (AU:TTX) has a market capitalization of $199.36 Million (AU$281.75 Million) as of November 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #16348 globally and #448 in its home market, demonstrating a 8.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tetratherix Ltd's stock price AU$5.55 by its total outstanding shares 50765665 (50.77 Million). Also see Tetratherix Ltd (TTX) cash flow conversion for how efficiently the company converts equity into cash flow.
Tetratherix Ltd Market Cap History (2025–2026)
Tetratherix Ltd market cap history from 2025 to 2026. Data shows growth from $117.82 Million to $199.36 Million (0.00% CAGR). Check Tetratherix Ltd stock quote for real-time trading data and today's change.
Tetratherix Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tetratherix Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Tetratherix Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
103.11x
Tetratherix Ltd's market cap is 103.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $117.82 Million | $1.14 Million | -$9.43 Million | 103.11x | N/A |
Competitor Companies of TTX by Market Capitalization
Companies near Tetratherix Ltd in the global market cap rankings as of November 4, 2026. Also see how large is Tetratherix Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Tetratherix Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Tetratherix Ltd (2025–2026)
Market capitalization of Tetratherix Ltd from 2025 to today. Between 2025 and today, Tetratherix Ltd's market cap moved from $117.82 Million to $ 199.36 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$199.36 Million | +69.21% |
| 2025 | AU$117.82 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Tetratherix Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $199.36 Million USD |
| MoneyControl | $199.36 Million USD |
| MarketWatch | $199.36 Million USD |
| marketcap.company | $199.36 Million USD |
| Reuters | $199.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.